Skip to main content

Table 1 General characteristics of 166 patients with infective endocarditis (IE)

From: Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy

 

No. (%) of patients

p

Characteristic

TOTAL

Native valve

Prosthetic valve

(189 events, 166 patients)

(118 events, 111 patients)

(71 events, 55 patients)

Age (years), median [IQR]

57 [43–72]

53 [42–71]

66 [50–75]

0.01

Male gender

104 (63%)

72 (65%)

32 (58%)

0.4

Time from onset of symptoms to admission

 
 

< 7 days

69 (37%)

41 (35%)

28 (39%)

 
 

>7 and ≤21 days

42 (22%)

25 (21%)

17 (24%)

 

> 21 days

55 (29%)

34 (29%)

21 (30%)

1

 

NA

23 (12%)

18 (15%)

5 (7%)

Co-morbidities

 
 

Cancer

14 (7%)

13 (11%)

1 (1%)

0.01

 

Hypertension

39 (21%)

21 (18%)

18 (25%)

0.2

 

Acute/chronic renal failure

17 (9%)

6 (5%)

11 (15%)

0.02

 

Ischemic cardiopathy

21 (11%)

9 (8%)

12 (17%)

0.05

 

Diabetes mellitus

29 (15%)

17 (14%)

12 (17%)

0.6

 

COPD

9 (5%)

4 (3%)

5 (7%)

0.2

 

CLD

55 (29%)

41 (35%)

14 (20%)

0.03

 

HIV infection

35 (19%)

27 (23%)

8 (11%)

0.05

 

   CD4 cells/μL [IQR]

268 [145–353]

248 [124–313]

447 [348–1814]

0.008

 

   HIV-RNA cp/mL (n 22)

    
 

   <10000

14 (40%)

8 (30%)

6 (75%)

 
 

   10000-100000

5 (14%)

4 (15%)

1 (13%)

0.11

 

   >100000

4 (11%)

4 (15%)

0

 
 

   NA

12 (34%)

11 (41%)

1 (13%)

 
 

   HAART at IE

    
 

   No

21 (60%)

15 (56%)

6 (75%)

0.2

 

   Yes

14 (40%)

12 (44%)

2 (25%)

 

Data are median [interquartile range] or numbers (%).

 
  1. NA, Not available; COPD, Chronic obstructive pulmonary disease; CLD, Chronic liver disease; HAART, Highly active antiretroviral therapy.